← Back to Search
Nanomedicines For Treatment Of Viral Diseases.
Rujuta Mehendale, M. Joshi, V. Patravale
Published 2013 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Viral diseases affect millions of people worldwide, with a high impact on human health and socioeconomic development. More than 40 million people are affected with human immunodeficiency virus (HIV) alone. This review discusses the various nanocarriers (e.g., liposomes, solid lipid nanoparticles, polymeric nanoparticles, inorganic nanoparticles, etc.) based on approaches that have been applied in the literature and in the clinic to combat the different challenges faced by the antiviral therapy. The recent developments in smart delivery technologies (e.g., immunoliposomes) targeting delivery to the lectin receptors and cell-penetrating peptides for site-specific delivery of antiviral agents at the viral reservoirs are also been discussed.
This paper references
Dendrimer toxicity: Let's meet the challenge.
K. Jain (2010)
Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
L. D. du Toit (2010)
Dendritic Catanionic Assemblies: In vitro Anti‐HIV Activity of Phosphorus‐Containing Dendrimers Bearing Galβ1cer Analogues
M. Blanzat (2005)
INTRAVITREAL INJECTION OF LIPOSOME‐ENCAPSULATED GANCICLOVIR IN A RABBIT MODEL
G. Peyman (1987)
SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study
F. Lai (2007)
Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles.
Dana Baram-Pinto (2010)
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.
Huanyu Dou (2007)
Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Y. Kuo (2011)
Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity
D. Tyssen (2010)
Nanosuspensions: a promising drug delivery strategy
V. Patravale (2004)
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).
D. Flasher (1994)
Novel anti-RSV dianionic dendrimer-like compounds: design, synthesis and biological evaluation.
A. Gazumyan (2000)
Recent advances in delivery systems for anti-HIV1 therapy
J. M. Lanao (2007)
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
C. Destache (2009)
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
H. L. Wong (2010)
Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.
H. Oka (2009)
Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther
L. Lu (2008)
Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles
A. S. Ham (2008)
Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line
N. Chattopadhyay (2008)
Multivalent glyconanoparticles with enhanced affinity to the anti-viral lectin Cyanovirin-N.
Xuxu Wang (2011)
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute.
Sung-Up Choi (2008)
Lymphatic targeting of zidovudine using surface-engineered liposomes
C. D. Kaur (2008)
Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles.
Y. Kuo (2009)
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
O. Borges (2007)
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
P. Sharma (2010)
Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.
Edwin Gong (2005)
Biomedical applications of dendrimers: a tutorial.
Meredith A. Mintzer (2011)
Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Jia-You Fang (2008)
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
Reginald Clayton (2009)
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.
Ari S. Nowacek (2011)
Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes
D. Bernstein (2003)
[Treatment of recurrent condyloma acuminatum with solid lipid nanoparticle gel containing podophyllotoxin: a randomized double-blinded, controlled clinical trial].
Fang-ming Xie (2007)
Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults
D. Powers (1997)
NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.
Ari S. Nowacek (2009)
The potential use of liposome-mediated antiviral therapy
W. Koff (1985)
Tumour and dendrimers: a review on drug delivery aspects
A. Agarwal (2008)
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1
Huanyu Dou (2009)
Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation
A. Kaur (2008)
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.
J. Zhou (2011)
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
P. Makidon (2008)
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
Progress in antiretroviral drug delivery using nanotechnology
R. Mallipeddi (2010)
Preparation and characterization of niosomes containing ribavirin for liver targeting
F. Hashim (2010)
The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
A. Chonn (1991)
Nanoparticulate Delivery Systems for Antiviral Drugs
D. Lembo (2010)
Interaction of silver nanoparticles with Tacaribe virus
Janice L. Speshock (2010)
Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
Y. Kuo (2011)
Ethical issues in clinical trials involving nanomedicine.
D. Resnik (2007)
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
V. Mishra (2006)
Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate.
Dana Baram-Pinto (2009)
Glycodendritic structures: promising new antiviral drugs.
Javier Rojo (2004)
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.
J. C. Leroux (1995)
AIDS Res Hum Retroviruses
A. Kamarulzaman (2006)
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
B. Fadeel (2010)
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers.
Jeffrey J. Landers (2002)
Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Y. Kuo (2007)
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
T. Dutta (2008)
Characterisation of copper oxide nanoparticles for antimicrobial applications.
G. Ren (2009)
A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation
J. Rogers (2008)
Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy
Zhang Xing-guo (2008)
Nevirapine nanosuspensions for HIV reservoir targeting.
R. Shegokar (2011)
Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells.
R. W. Sun (2005)
VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection
R. Rupp (2007)
Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
M. Witvrouw (2000)
A review of chitin and chitosan applications
M. Kumar (2000)
Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.
K. Borgmann (2011)
Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells
Stephanie Pollock (2010)
Stimulation of Kupffer cell tumoricidal activity by liposomal muramyl dipeptides.
N. Phillips (1992)
Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effect of methods of preparation
N. Bapat (1992)
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
M. P. Desai (2004)
Synthesis and characterization of cross-linked malonylchitosan microspheres for controlled release of acyclovir
H. K. Stulzer (2008)
Exploiting M cells for drug and vaccine delivery.
M. A. Clark (2001)
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.
A. Bender (1996)
Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection
N. Bourne (2000)
Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles.
A. Bender (1994)
Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Ho-Jin Moon (2012)
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.
F. De Jaeghere (2000)
Sustained Cytoplasmic Delivery and Anti-viral Effect of PLGA Nanoparticles Carrying a Nucleic Acid-Hydrolyzing Monoclonal Antibody
Y. K. Joung (2011)
Ultrasonication of chitosan and chitosan nanoparticles.
E. S. Tang (2003)
Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro
Upendhar Gandapu (2011)
Recent advances in stealth coating of nanoparticle drug delivery systems.
Z. Amoozgar (2012)
Interaction of silver nanoparticles with HIV-1
J. L. Elechiguerra (2005)
Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Y. Kuo (2008)
A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.
R. Muzzalupo (2011)
Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.
J. Reuter (1999)
Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Y. Kuo (2006)
In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy.
R. Shegokar (2011)
Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting
V. Schaefer (2004)
Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.
Tushar K Vyas (2008)
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
Polymeric Nanoparticles for Enhancing Antiretroviral Drug Therapy
T. Govender (2008)
Mucoadhesive Microspheres for Gastroretentive Delivery of Acyclovir: In Vitro and In Vivo Evaluation
S. Dhaliwal (2008)
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice.
C. Destache (2010)
Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.
J. Rollinger (2008)
Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.
T. D. Mccarthy (2005)
Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation.
R. Shegokar (2011)
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.
S. Telwatte (2011)
Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS
Lipa K Shah (2006)
Bacteria and bacteriophage inactivation by silver and zinc oxide nanoparticles.
Jia You (2011)
Pulmonary delivery of antiviral drugs in liposome aerosols
B. Gilbert (1996)
Body distribution of azidothymidine bound to nanoparticles after oral administration
R. Löbenberg (1997)
Preparation of fluoroalkyl end-capped cooligomers/silica nanoparticles: A new approach to fluorinated nanoparticle inhibitors of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus (SIVmac)
H. Sawada (2007)
Biodistribution of a 153Gd-Folate Dendrimer, Generation = 4, in Mice With Folate-Receptor Positive and Negative Ovarian Tumor Xenografts
S. Konda (2002)
Nanoparticle-based vaginal drug delivery systems for HIV prevention
R. Mallipeddi (2010)
Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Y. Gong (2002)
Sustained release of acyclovir from nano-liposomes and nano-niosomes: An in vitro study
B. Mukherjee (2007)
Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
H. Schreier (1994)
Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics
Ari S. Nowacek (2010)
Drug targeting systems for antiviral agents: options and limitations.
D. Meijer (1992)
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
Applications of liposomes in ophthalmology.
S. Ebrahim (2005)
Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications
Ashish Dev (2010)
Peritoneal Macrophage Uptake, Pharmacokinetics and Biodistribution of Macrophage-Targeted PEG-fMLF (N-Formyl-Methionyl-Leucyl-Phenylalanine) Nanocarriers for Improving HIV Drug Delivery
L. Wan (2007)
Lipid nanoparticles for parenteral delivery of actives.
Medha D. Joshi (2009)
Targeting of 3′-Azido 3′-Deoxythymidine (AZT)-Loaded Poly(Isohexylcyanoacrylate) Nanospheres to the Gastrointestinal Mucosa and Associated Lymphoid Tissues
Assia Dembri (2004)
Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor.
V. Slepushkin (1996)
Stavudine‐loaded mannosylated liposomes: in‐vitro anti‐HIV‐I activity, tissue distribution and pharmacokinetics
M. Garg (2006)
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
A. Gabizon (1988)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
Gerben van 't Klooster (2010)
Formation and Stability of Nano-Emulsions Prepared Using the Phase Inversion Temperature Method
P. Izquierdo (2002)
Formulation and evaluation of Acyclovir niosomes for ophthalmic use
Ahmed N. Allam (2011)
Influence of Generation 2–5 of PAMAM Dendrimer on the Inhibition of Tat Peptide/ TAR RNA Binding in HIV‐1 Transcription
W. Wang (2006)
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent.
M. Ali (2008)
Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
Reginald Clayton (2007)
Inactivation of Ebola virus with a surfactant nanoemulsion.
A. Chepurnov (2003)
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
S. Jain (2008)
Adv. Drug Delivery Rev.
F. Welt (1997)
Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles.
Ilona Papp (2010)
Chitosan‐tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability
A. Hasanovic (2009)
Comparing anti-HIV, antibacterial, antifungal, micellar, and cytotoxic properties of tricarboxylato dendritic amphiphiles.
Richard V. Macri (2009)
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
Dendrimers as therapeutic agents: a systematic review
V. Gajbhiye (2009)
Optimisation of multiple W/O/W nanoemulsions for dermal delivery of aciclovir.
J. Schwarz (2012)
Silver nanoparticles inhibit hepatitis B virus replication.
L. Lu (2008)
Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes.
S. Norley (1987)
Mode of antiviral action of silver nanoparticles against HIV-1
H. H. Lara (2010)
The role of liposomes in drug delivery and diagnostic imaging: a review.
M. L. Matteucci (2000)
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
Dispersions of lamellar phases of non‐ionic lipids in cosmetic products
R. Handjani-Vila (1979)
Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells.
Tomer Bronshtein (2011)
Improving Drug Delivery to Intracerebral Tumor and Surrounding Brain in a Rodent Model: A Comparison of Osmotic versus Bradykinin Modification of the Blood-Brain and/or Blood-Tumor Barriers
Robert A. Kroll (1998)
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
U. Gupta (2010)
Silver Nanoparticles as Potential Antiviral Agents
Stefania Galdiero (2011)
Nanotechnology and HIV: potential applications for treatment and prevention.
P. Kim (2010)
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
Were LL Munyendo (2012)
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.
Huanyu Dou (2006)
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.
R. Löbenberg (1998)
Potential of solid lipid nanoparticles in brain targeting.
I. P. Kaur (2008)
Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
T. Kubo (2000)
Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome.
N. Phillips (1992)
Potential of polymeric nanoparticles in AIDS treatment and prevention
N. Khalil (2011)
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
S. Mahajan (2010)
SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques.
Y. Jiang (2005)
Key issues in non-viral gene delivery: Adv Drug Deliv Rev
C. Pouton (1998)
Non-ionic surfactant based vesicles (niosomes) in drug delivery
I. Uchegbu (1998)
Prevention of Murine Influenza a Virus Pneumonitis by Surfactant Nano-Emulsions
B. Donovan (2000)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 Transmission
C. Dezzutti (2004)
Synthesis and characterization of semi-interpenetrating polymer network microspheres of acrylamide grafted dextran and chitosan for controlled release of acyclovir
A. P. Rokhade (2007)
Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
N. Gupta (2011)
Inorganic nanoparticles as carriers for efficient cellular delivery
Z. P. Xu (2006)
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
Key issues in non-viral gene delivery.
C. Pouton (2001)
This paper is referenced by
Synthesis of zinc oxide nanoparticles and evaluated its activity against bacterial isolates
S. Albukhaty (2020)
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
G. Islan (2017)
Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection.
A. Date (2015)
Application of Virus Targeting Nanocarrier Drug Delivery System in Virus-Induced Central Nervous System Disease Treatment.
S. Zhu (2019)
NANOBIOTECHNOLOGY: A POTENTIAL TOOL FOR BIOMEDICS
Vikas Shrivastava (2015)
Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections
D. Lembo (2018)
Preparation and Characterization of Gelatin-Stavudine Conjugated Liposomal Nanoparticles for Better Delivery in Case Of HIV
Ankita Boxi (2015)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
V. Torchilin (2014)
Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection
B. Dey (2015)
Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles.
E. Russo (2014)
Shell Cross-Linked Polymeric Micelles as Camptothecin Nanocarriers for Anti-HCV Therapy.
I. Jiménez-Pardo (2015)
Nanostructures based on ammonium-terminated amphiphilic Janus dendrimers as camptothecin carriers with antiviral activity
A. Lancelot (2017)
Applying Nanoparticles in the Treatment of Viral Infections and Toxicological Considerations
Zohreh Fasili (2020)
Pharmaceutical and biomedical applications of lipid-based nanocarriers.
C. Carbone (2014)
Current applications of nanoparticles in infectious diseases.
H. Zazo (2016)
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.
A. Tseng (2015)
Recent progress in dendrimer-based nanomedicine development
Yejin Kim (2018)
The role of nanotechnology in the treatment of viral infections
Lavanya Singh (2017)
DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding
C. Li (2016)